Ketamine rescheduling consultation
This was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government
This consultation has concluded
Download the full outcome
Consultation on proposals to reschedule ketamine from part 1 of schedule 4 to schedule 2 to the Misuse of Drugs Regulations 2001: summary of responses
PDF, 271KB, 7 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
Detail of outcome
This document sets out the government’s response to the issues raised during the consultation on proposals to reschedule ketamine from Part 1 of Schedule 4 to Schedule 2 to the Misuse of Drugs Regulations 2001.
The government’s response to the issues raised during the consultation on proposals to introduce electronic prescribing of Schedule 2 and 3 controlled drugs for NHS and private prescribers is available.
This consultation ran from
This consultation seeks your views on the Advisory Council on the Misuse of Drugs’ (ACMD) recommendation to reschedule ketamine to Schedule 2 to the Misuse of Drugs Regulations 2001 (as amended) (the 2001 Regulations).
PDF, 80.4KB, 15 pages
PDF, 500KB, 15 pages
This follows reclassification under the Misuse of Drugs Act 1971 (the 1971 Act) as a Class B drug on 10 June 2014.
More specifically on the record keeping, prescribing and safe custody requirements applicable to Schedule 2 drugs. Ketamine is currently a Schedule 4 Part 1 drug and therefore lightly regulated. These proposals have been prepared in discussion with the ACMD and the Department of Health.
How to respond
You can respond online.
Alternatively you can send your answers to these questions, together with any other comments, by email to have your say no later than Monday 3 November 2014.
If you prefer you can post your responses to:
Drug Legislation Team, Drugs and Alcohol Unit
5th Floor (NE)
2 Marsham Street